Conditions of metabolic dysfunction, such as obesity and diabetes, are associated with increased PTP1B expression in the brain and metabolic tissues [3–5], which provides a potential explanation for the development of insulin resistance. This evidence concerns the gene PTPN1 and obesity disorder.